PAION AG

PAION AG (FRA:PA8)

27/01/2023 12:59

EQS-Adhoc: PAION receives positive CHMP opinion recommending approval of remimazolam for the induction and maintenance of general anesthesia in adults

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

25/01/2023 17:35

EQS-News: PAION AG: Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

19/01/2023 10:30

EQS-News: PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE CRISTÁLIA IN BRASIL

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

16/12/2022 10:19

EQS-News: PAION AG issues statement on planned capital measure

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

14/12/2022 13:41

EQS-Adhoc: PAION AG convenes extraordinary general meeting for capital reductions by redemption and consolidation of shares

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

30/11/2022 17:28

EQS-News: PAION AG announces change in Management Board

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

30/11/2022 17:21

EQS-Adhoc: PAION AG: CEO Dr. James Phillips leaves the Company as of 30 November 2022, appointment of Supervisory Board member Gregor Siebert as member and new CEO until 30 November 2023

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

16/11/2022 11:40

EQS-News: PAION AG enters partnership with Viatris and expands sales activities in Europe

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

16/11/2022 07:30

EQS-News: PAION AG reports financial results for the first nine months of 2022

Voir tous les communiqués de PAION AG

PAION AG (FRA:PA8)

15/11/2022 16:28

EQS-Adhoc: PAION AG raises EBITDA forecast for fiscal year 2022

Voir tous les communiqués de PAION AG

1
2
3
4
5
6
7
8
»